Effect of nitric oxide on responses of the human uterine arteries to vasopressin

Vascular Pharmacology

Volumn 48, Issue 1, 2008, Pages 9-13

  Kostrzewska, Anna ^a   Modzelewska, Beata ^a   Kleszczewski, Tomasz ^a   Batra, Satish ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Nitric oxide; Potassium channel; Vasopressin

Indexed keywords

ADENOSINE TRIPHOSPHATE; APAMIN; CALCIUM; CHARYBDOTOXIN; GLIBENCLAMIDE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL; VASOPRESSIN;

ARTICLE; BLOOD VESSEL TONE; CONDUCTANCE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; UTERINE ARTERY;

ADULT; ANALYSIS OF VARIANCE; APAMIN; ARGININE VASOPRESSIN; ARTERIES; CHARYBDOTOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GLYBURIDE; HUMANS; KATP CHANNELS; MEMBRANE POTENTIALS; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITROARGININE; NITROPRUSSIDE; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; POTASSIUM CHLORIDE; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; UTERUS; VASOCONSTRICTION;

EID: 38349138258     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2007.09.003     Document Type: Article

References (22)

1. Birnbaumer M. Vasopressin receptors. Trends Endocrinol. Metab. 11 (2000) 406-410
2. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., and Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368 (1994) 850-853
3. Bracamonte M.P., Burnett J., J.C., and Miller V.M. Activation of soluble guanylate cyclase and potassium channels contribute to relaxation to nitric oxide in smooth muscle derived from canine femoral veins. J. Cardiovasc. Pharmacol. 34 (1999) 407-413
4. Bychkov R., Gollasch M., Steinke T., Ried C., Luft F.C., and Haller H. Calcium-activated potassium channels and nitrate-induced vasodilation in human coronary arteries. J. Pharmacol. Exp.Ther. 285 (1998) 293-298
5. Chan C.C., Lee F.Y., Wang S.S., Chang F.Y., Lin H.C., Chu C.J., Tai C.C., Lai I.N., and Lee S.D. Effects of vasopressin on portal-systemic collaterals in portal hypertensive rats: role of nitric oxide and prostaglandins. Hepatology. 30 (1999) 630-635
6. Fukami Y., Toki Y., Numaguchi Y., Nakashima Y., Mukawa H., Matsui H., Okumara K., and Ito T. Nitrolycerin-induced aortic relaxation mediated by calcium-activated potassium channel is markedly diminished in hypertensive rats. Life Sci. 63 (1998) 1047-1055
7. Gardiner S.M., Compton A.M., Kemp P.A., and Bennett T. Effect of NG-nitro-l-arginine methyl ester or indomethacin on differential regional and cardiac hemodynamic action of arginine vasopressin and lysine vasopressin in conscious rats. Br. J. Pharmacol. 102 (1991) 65-72
8. Hennan J.K., and Diamond J. Evidence that spontaneous contractile activity in the rat myometrium is not inhibited by NO-mediated increases in tissue levels of cyclic GMP. Br. J. Pharmacol. 123 (1998) 959-967
9. Jovanovic A., Grbovic L., and Tulic I. l-arginine induces relaxation of human uterine artery with both intact and denuded endothelium. Eur. J. Pharmacol. 256 (1994) 103-107
10. Kaczorowski G.J., and Garcia M.L. Pharmacology of voltage-gated and calcium-activated potassium channels. Curr. Opin. Cheml. Biol. 3 (1999) 448-458
11. + efflux in rat isolated aorta. Naunyn-Schmideberg's Arch. Pharmacol. 355 (1997) 483-490
12. 1a receptor antagonist SR 49059, on the response of human uterine arteries to vasopressin and other vasoactive substances. Acta Obstet. Gynecol. Scand. 77 (1998) 3-7
13. MacKinnon R., and Miller C. Mechanism of charybdotoxin block of the high-conductance, Ca2+-activated K+ channel. J. Gen. Physiol. 91 (1988) 335-349
14. Minami K., Fukuzawa K., and Nakaya Y. Protein kinase C inhibits the Ca(2+)-activated K+ channel of cultured porcine coronary artery smooth muscle cells. Biochem. Biophys. Res. Commun. 190 (1993) 263-269
15. Murphy M.E., and Brayden J.E. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J. Physiol. 486 Pt 1 (1995) 47-58
16. +currents in smooth muscle cells from rabbit mesenteric artery. Am. J. Physiol. 269 (1995) C1112-C1118
17. Salvucci A., and Armstead W.M. Vasopressin impairs K(ATP) and K(ca) channel function after brain injury. Brain Res. 887 (2000) 406-412
18. Schubert R., and Nelson M.T. Protein kinases: tuners of the BKCa channel in smooth muscle. Trends Pharmacol. Sci. 22 (2000) 505-512
19. Schubert R., Noack T., and Serebryakov V.N. Protein kinase C reduces the KCa current of rat tail artery smooth muscle cells. Am. J. Physiol. 276 (1999) C648-C658
20. Simonsen U., Prieto D., Delgado J.A., Hernández M., Resel L., Saenz de Tejada I., and García-Sacristán A. Nitric oxide is involved in the inhibitory neurotransmission and endothelium-dependent relaxations of human small penile arteries. Clin. Sci. (Colch). 92 (1997) 269-275
21. Wakatsuki T., Nakaya Y., and Inoue I. Vasopressin modulates K-channel activities of cultured smooth muscle cells from porcine coronary artery. Am. J. Physiol. 263 (1992) H491-H496
22. Zhao Y.J., Wang J., Rubin L.J., and Yuan X.J. Inhibition of K(V) and K(Ca) channels antagonizes NO-induced relaxation in pulmonary artery. Am. J. Physiol. 272 (1997) H904-H912